acetic acid has been researched along with Bronchopulmonary Dysplasia in 2 studies
Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frazer, LC | 1 |
| Yakah, W | 1 |
| Martin, CR | 1 |
| Spence, KL | 1 |
| Zozobrado, JC | 1 |
| Patterson, BW | 1 |
| Hamvas, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Collaborative Research Group for Necrotizing Enterocolitis[NCT00828451] | 29 participants (Actual) | Interventional | 2008-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Identification of computationally predicted functional variants in EGF gene (NCT00828451)
Timeframe: Sampling occurred on average day of life 9 with a range from day of life 7 to 21
| Intervention | percentage of participants with variant (Number) |
|---|---|
| Preterm Infants for EGF Profiles | 11 |
Salivary EGF protein levels obtained from oral swabs were analyzed by commercially available EGF ELISA kit (R &D systems Inc). EGF protein levels were normalized to micrograms of protein in saliva, and expressed as picogram of EGF protein per microgram of total salivary protein. (NCT00828451)
Timeframe: Sampling occurred on average day of life 9 with a range from day of life 7 to 21
| Intervention | picograms EGF/ microgram of protein (Median) |
|---|---|
| Preterm Infants for EGF Profiles | 15 |
Urinary EGF protein levels obtained from free flowing urine samples retrieved from subject diaper were analyzed by commercially available EGF ELISA kit (R &D systems Inc). EGF protein levels were normalized to milligrams of creatinine in urine, and expressed as nanograms of EGF protein per milligram of urinary creatinine. (NCT00828451)
Timeframe: Sampling occurred on average day of life 9 with a range from day of life 7 to 21
| Intervention | nanograms of EGF/mg of creatinine (Median) |
|---|---|
| Preterm Infants for EGF Profiles | 48 |
2 other studies available for acetic acid and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Decreased Acetic Acid in the Stool of Preterm Infants Is Associated with an Increased Risk of Bronchopulmonary Dysplasia.
Topics: Acetic Acid; Adult; Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant; Infant, Newborn; In | 2022 |
Substrate utilization and kinetics of surfactant metabolism in evolving bronchopulmonary dysplasia.
Topics: Acetic Acid; Age Factors; Bronchopulmonary Dysplasia; Carbon Isotopes; Female; Humans; Hyaline Membr | 2005 |